Using advanced protein biomarker approaches to better understand COVID-19

Webinar title: "Using advance protein biomarker approaches to better understand rare disease and COVID-19"

In this webinar, Dr. Frank Schmidt discusses two clinical studies run by the Weill Cornell Medicine Proteomics core using Olink protein assays to understand COVID-19. These two studies were then included in an inter-study comparison to find commonalities in the findings of important protein biomarkers in the disease.

Watch the webinar to learn more about:

  • Dr. Schmidt's discovery that the same inflammatory proteins were elevated in patients suffering from ARDS resulting from COVID-19, influenza, and bacterial sepsis
  • How Dr Schmidt combined metabolomic and proteomic data to compare patients who were hospitalized due to COVID-19 vs another disease
  • Their findings of 37 proteins that were common in all five clinical studies that were compared in their meta analysis



Dr. Frank Schmidt

Associate Professor of Biochemistry, Weill Cornell Medical College, Qatar

Watch the recording now!